Sil Suhasini, Kaur Daljit, Chawla Latika, Kumari Dixa, Singh Madhulika, Prasanth Vaidehi, Jain Ashish, Negi Gita
Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.
Department of Transfusion Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Asian J Transfus Sci. 2025 Jan-Jun;19(1):141-144. doi: 10.4103/ajts.ajts_155_23. Epub 2024 Feb 6.
Transplacental ultrasound-guided intrauterine transfusion (IUT) acts as a lifesaving therapy to prevent fetal anemia or even to reverse fetal hydrops. IUTs are generally initiated after 22-24 weeks of gestation and repeated every 2-4-week period of gestation. Although Rh-Kell phenotype-matched, fresh irradiated leukoreduced donor-packed red cells help to increase fetal hemoglobin level, this invasive procedure can increase fetal complications by fetomaternal hemorrhage. Women receiving IUTs are noted to be high allo-responders to red cell antigens, which can cause enhanced antibody titer or the formation of additional antibodies which might complicate future pregnancies. Hereby, we are reporting the case of a multiparous woman who underwent three sessions of IUTs between 24 weeks and 31+-week period of gestation and developed an additional anti-C antibody which was incidentally detected during compatibility testing at 34 weeks, along with raised anti-D immunoglobulin G titer of 1024 from initial titer of 128.
经胎盘超声引导下宫内输血(IUT)是一种挽救胎儿生命的治疗方法,用于预防胎儿贫血甚至逆转胎儿水肿。IUT通常在妊娠22 - 24周后开始,每隔2 - 4周重复进行一次。尽管Rh - Kell血型匹配的新鲜辐照去白细胞供体浓缩红细胞有助于提高胎儿血红蛋白水平,但这种侵入性操作可能因母胎出血而增加胎儿并发症。接受IUT的女性被认为是红细胞抗原的高同种反应者,这可能导致抗体效价升高或形成额外抗体,从而使未来妊娠复杂化。在此,我们报告一例经产妇的病例,该产妇在妊娠24周和31 +周期间接受了三次IUT,在34周进行相容性检测时意外检测到一种额外的抗 - C抗体,同时抗 - D免疫球蛋白G效价从初始的128升高到1024。